← Back to Calendar

ASH Annual Meeting 2026

American Society of Hematology
Standard Review Major Conference
Catalyst Date
December 12, 2026
Time Remaining
243 days
Review Type
Standard (10 mo)
Track ASH Annual Meeting 2026 catalysts → get weekly FDA alerts Subscribe Free on Substack →

Indication

Hematology — New Orleans, LA

Key Notes

ASH Annual Meeting 2026: December 12–15, Ernest N. Morial Convention Center, New Orleans, LA. Premier hematology conference — key data for sickle cell disease, AML, MDS, myeloma, and MPN drugs. Watch for Geron (imetelstat/Rytelo), Rocket Pharma (KRESLADI), and Alnylam data.
⚠️ Not Investment Advice: This information is provided for educational purposes only. PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period, issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on historical base rates and do not account for drug-specific factors. Always consult a financial advisor before making investment decisions.

Discussion

Share your analysis, research, or questions about this catalyst. No account required.

Rate limit: 5/hr per email
Loading comments...
← Back to Full Calendar